Literature DB >> 18417655

Norovirus excretion in an aged-care setting.

Elise T-V Tu1, Rowena A Bull, Mi-Jurng Kim, Christopher J McIver, Leon Heron, William D Rawlinson, Peter A White.   

Abstract

Norovirus genogroup II excretion during an outbreak of gastroenteritis was investigated in an aged-care facility. Viral shedding peaked in the acute stage of illness and continued for an average of 28.7 days. The viral decay rate was 0.76 per day, which corresponds to a viral half-life of 2.5 days.

Entities:  

Mesh:

Year:  2008        PMID: 18417655      PMCID: PMC2446857          DOI: 10.1128/JCM.02198-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Molecular and epidemiological features of norovirus-associated gastroenteritis outbreaks in Victoria, Australia in 2001.

Authors:  John A Marshall; Anna Dimitriadis; Peter J Wright
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

2.  Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004.

Authors:  Lenee H Blanton; Susan M Adams; R Suzanne Beard; Gang Wei; Sandra N Bulens; Marc-Alain Widdowson; Roger I Glass; Stephan S Monroe
Journal:  J Infect Dis       Date:  2005-12-21       Impact factor: 5.226

Review 3.  The epidemiologic and clinical importance of norovirus infection.

Authors:  Robert L Atmar; Mary K Estes
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

4.  Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis.

Authors:  Rowena A Bull; Elise T V Tu; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

6.  Evaluation and validation of real-time reverse transcription-pcr assay using the LightCycler system for detection and quantitation of norovirus.

Authors:  Xiaoli Pang; Bonita Lee; Linda Chui; Jutta K Preiksaitis; Stephan S Monroe
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b.

Authors:  Elise T-V Tu; Rowena A Bull; Gail E Greening; Joanne Hewitt; Michael J Lyon; John A Marshall; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

8.  Inactivation of feline calicivirus, a Norwalk virus surrogate.

Authors:  J C Doultree; J D Druce; C J Birch; D S Bowden; J A Marshall
Journal:  J Hosp Infect       Date:  1999-01       Impact factor: 3.926

9.  Fecal viral load and norovirus-associated gastroenteritis.

Authors:  Martin C W Chan; Joseph J Y Sung; Rebecca K Y Lam; Paul K S Chan; Nelson L S Lee; Raymond W M Lai; Wai K Leung
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

10.  Norovirus recombination in ORF1/ORF2 overlap.

Authors:  Rowena A Bull; Grant S Hansman; Leighton E Clancy; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

View more
  30 in total

1.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.

Authors:  Auda A Eltahla; Kun Lee Lim; John-Sebastian Eden; Andrew G Kelly; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  Slow Clearance of Norovirus following Infection with Emerging Variants of Genotype GII.4 Strains.

Authors:  Lars Gustavsson; Rickard Nordén; Johan Westin; Magnus Lindh; Lars-Magnus Andersson
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

4.  Contribution of intra- and interhost dynamics to norovirus evolution.

Authors:  Rowena A Bull; John-Sebastian Eden; Fabio Luciani; Kerensa McElroy; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 5.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

6.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants.

Authors:  J Joukje Siebenga; Philippe Lemey; Sergei L Kosakovsky Pond; Andrew Rambaut; Harry Vennema; Marion Koopmans
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

8.  Epidemiology of foodborne Norovirus outbreak in Incheon, Korea.

Authors:  Jun-Hwan Yu; Na-Yeon Kim; Yeon-Ja Koh; Hun-Jae Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

9.  New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children.

Authors:  C Henke-Gendo; G Harste; B Juergens-Saathoff; F Mattner; H Deppe; A Heim
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

10.  Spontaneous bowel perforation due to norovirus: a case report.

Authors:  Nikhil Pawa; Andrew P Vanezis; Matthew G Tutton
Journal:  Cases J       Date:  2009-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.